Rosuvastatin Calcium Industry Research Report 2024

Rosuvastatin Calcium Industry Research Report 2024


Summary
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.

According to APO Research, the global Rosuvastatin Calcium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Rosuvastatin Calcium include AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm and Zhejiang Hisun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Calcium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Calcium.

The report will help the Rosuvastatin Calcium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Rosuvastatin Calcium market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rosuvastatin Calcium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
AstraZenecaTeva Pharmaceutical IndustriesMSN LaboratoriesCadila PharmaceuticalsLGM PharmaBal PharmaChangzhou Pharmaceutical FactoryJingxin PharmZhejiang Hisun PharmaceuticalHEC PharmLunan PharmaceuticalNanjing Frochem TechLianyungang Runzhong PharmaceuticalShandong Bechem ChemicalsCTX Life SciencesRosuvastatin Calcium segment by Type
Purity 98.0%Purity 99.0%OtherRosuvastatin Calcium segment by Application
Tablet (including dispersible tablet and general tablet)CapsuleOthersRosuvastatin Calcium Segment by Region
North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaChina TaiwanIndonesiaThailandMalaysiaLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaUAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rosuvastatin Calcium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rosuvastatin Calcium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rosuvastatin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Rosuvastatin Calcium Market Size (2019-2030) & (US$ Million)
2.2.2 Global Rosuvastatin Calcium Sales (2019-2030)
2.2.3 Global Rosuvastatin Calcium Market Average Price (2019-2030)
2.3 Rosuvastatin Calcium by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Purity 98.0%
2.3.3 Purity 99.0%
2.3.4 Other
2.4 Rosuvastatin Calcium by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Tablet (including dispersible tablet and general tablet)
2.4.3 Capsule
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Rosuvastatin Calcium Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Rosuvastatin Calcium Sales (Kg) of Manufacturers (2019-2024)
3.3 Global Rosuvastatin Calcium Revenue of Manufacturers (2019-2024)
3.4 Global Rosuvastatin Calcium Average Price by Manufacturers (2019-2024)
3.5 Global Rosuvastatin Calcium Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Rosuvastatin Calcium, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Rosuvastatin Calcium, Product Type & Application
3.8 Global Manufacturers of Rosuvastatin Calcium, Date of Enter into This Industry
3.9 Global Rosuvastatin Calcium Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 AstraZeneca
4.1.1 AstraZeneca Company Information
4.1.2 AstraZeneca Business Overview
4.1.3 AstraZeneca Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.1.4 AstraZeneca Rosuvastatin Calcium Product Portfolio
4.1.5 AstraZeneca Recent Developments
4.2 Teva Pharmaceutical Industries
4.2.1 Teva Pharmaceutical Industries Company Information
4.2.2 Teva Pharmaceutical Industries Business Overview
4.2.3 Teva Pharmaceutical Industries Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Teva Pharmaceutical Industries Rosuvastatin Calcium Product Portfolio
4.2.5 Teva Pharmaceutical Industries Recent Developments
4.3 MSN Laboratories
4.3.1 MSN Laboratories Company Information
4.3.2 MSN Laboratories Business Overview
4.3.3 MSN Laboratories Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.3.4 MSN Laboratories Rosuvastatin Calcium Product Portfolio
4.3.5 MSN Laboratories Recent Developments
4.4 Cadila Pharmaceuticals
4.4.1 Cadila Pharmaceuticals Company Information
4.4.2 Cadila Pharmaceuticals Business Overview
4.4.3 Cadila Pharmaceuticals Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Cadila Pharmaceuticals Rosuvastatin Calcium Product Portfolio
4.4.5 Cadila Pharmaceuticals Recent Developments
4.5 LGM Pharma
4.5.1 LGM Pharma Company Information
4.5.2 LGM Pharma Business Overview
4.5.3 LGM Pharma Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.5.4 LGM Pharma Rosuvastatin Calcium Product Portfolio
4.5.5 LGM Pharma Recent Developments
4.6 Bal Pharma
4.6.1 Bal Pharma Company Information
4.6.2 Bal Pharma Business Overview
4.6.3 Bal Pharma Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Bal Pharma Rosuvastatin Calcium Product Portfolio
4.6.5 Bal Pharma Recent Developments
4.7 Changzhou Pharmaceutical Factory
4.7.1 Changzhou Pharmaceutical Factory Company Information
4.7.2 Changzhou Pharmaceutical Factory Business Overview
4.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Product Portfolio
4.7.5 Changzhou Pharmaceutical Factory Recent Developments
4.8 Jingxin Pharm
4.8.1 Jingxin Pharm Company Information
4.8.2 Jingxin Pharm Business Overview
4.8.3 Jingxin Pharm Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Jingxin Pharm Rosuvastatin Calcium Product Portfolio
4.8.5 Jingxin Pharm Recent Developments
4.9 Zhejiang Hisun Pharmaceutical
4.9.1 Zhejiang Hisun Pharmaceutical Company Information
4.9.2 Zhejiang Hisun Pharmaceutical Business Overview
4.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Product Portfolio
4.9.5 Zhejiang Hisun Pharmaceutical Recent Developments
4.10 HEC Pharm
4.10.1 HEC Pharm Company Information
4.10.2 HEC Pharm Business Overview
4.10.3 HEC Pharm Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.10.4 HEC Pharm Rosuvastatin Calcium Product Portfolio
4.10.5 HEC Pharm Recent Developments
4.11 Lunan Pharmaceutical
4.11.1 Lunan Pharmaceutical Company Information
4.11.2 Lunan Pharmaceutical Business Overview
4.11.3 Lunan Pharmaceutical Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Lunan Pharmaceutical Rosuvastatin Calcium Product Portfolio
4.11.5 Lunan Pharmaceutical Recent Developments
4.12 Nanjing Frochem Tech
4.12.1 Nanjing Frochem Tech Company Information
4.12.2 Nanjing Frochem Tech Business Overview
4.12.3 Nanjing Frochem Tech Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Nanjing Frochem Tech Rosuvastatin Calcium Product Portfolio
4.12.5 Nanjing Frochem Tech Recent Developments
4.13 Lianyungang Runzhong Pharmaceutical
4.13.1 Lianyungang Runzhong Pharmaceutical Company Information
4.13.2 Lianyungang Runzhong Pharmaceutical Business Overview
4.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Product Portfolio
4.13.5 Lianyungang Runzhong Pharmaceutical Recent Developments
4.14 Shandong Bechem Chemicals
4.14.1 Shandong Bechem Chemicals Company Information
4.14.2 Shandong Bechem Chemicals Business Overview
4.14.3 Shandong Bechem Chemicals Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Shandong Bechem Chemicals Rosuvastatin Calcium Product Portfolio
4.14.5 Shandong Bechem Chemicals Recent Developments
4.15 CTX Life Sciences
4.15.1 CTX Life Sciences Company Information
4.15.2 CTX Life Sciences Business Overview
4.15.3 CTX Life Sciences Rosuvastatin Calcium Sales, Revenue and Gross Margin (2019-2024)
4.15.4 CTX Life Sciences Rosuvastatin Calcium Product Portfolio
4.15.5 CTX Life Sciences Recent Developments
5 Global Rosuvastatin Calcium Market Scenario by Region
5.1 Global Rosuvastatin Calcium Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Rosuvastatin Calcium Sales by Region: 2019-2030
5.2.1 Global Rosuvastatin Calcium Sales by Region: 2019-2024
5.2.2 Global Rosuvastatin Calcium Sales by Region: 2025-2030
5.3 Global Rosuvastatin Calcium Revenue by Region: 2019-2030
5.3.1 Global Rosuvastatin Calcium Revenue by Region: 2019-2024
5.3.2 Global Rosuvastatin Calcium Revenue by Region: 2025-2030
5.4 North America Rosuvastatin Calcium Market Facts & Figures by Country
5.4.1 North America Rosuvastatin Calcium Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Rosuvastatin Calcium Sales by Country (2019-2030)
5.4.3 North America Rosuvastatin Calcium Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Rosuvastatin Calcium Market Facts & Figures by Country
5.5.1 Europe Rosuvastatin Calcium Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Rosuvastatin Calcium Sales by Country (2019-2030)
5.5.3 Europe Rosuvastatin Calcium Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Rosuvastatin Calcium Market Facts & Figures by Country
5.6.1 Asia Pacific Rosuvastatin Calcium Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Rosuvastatin Calcium Sales by Country (2019-2030)
5.6.3 Asia Pacific Rosuvastatin Calcium Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Rosuvastatin Calcium Market Facts & Figures by Country
5.7.1 Latin America Rosuvastatin Calcium Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Rosuvastatin Calcium Sales by Country (2019-2030)
5.7.3 Latin America Rosuvastatin Calcium Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Rosuvastatin Calcium Market Facts & Figures by Country
5.8.1 Middle East and Africa Rosuvastatin Calcium Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Rosuvastatin Calcium Sales by Country (2019-2030)
5.8.3 Middle East and Africa Rosuvastatin Calcium Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Rosuvastatin Calcium Sales by Type (2019-2030)
6.1.1 Global Rosuvastatin Calcium Sales by Type (2019-2030) & (Kg)
6.1.2 Global Rosuvastatin Calcium Sales Market Share by Type (2019-2030)
6.2 Global Rosuvastatin Calcium Revenue by Type (2019-2030)
6.2.1 Global Rosuvastatin Calcium Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Rosuvastatin Calcium Revenue Market Share by Type (2019-2030)
6.3 Global Rosuvastatin Calcium Price by Type (2019-2030)
7 Segment by Application
7.1 Global Rosuvastatin Calcium Sales by Application (2019-2030)
7.1.1 Global Rosuvastatin Calcium Sales by Application (2019-2030) & (Kg)
7.1.2 Global Rosuvastatin Calcium Sales Market Share by Application (2019-2030)
7.2 Global Rosuvastatin Calcium Revenue by Application (2019-2030)
7.2.1 Global Rosuvastatin Calcium Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Rosuvastatin Calcium Revenue Market Share by Application (2019-2030)
7.3 Global Rosuvastatin Calcium Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Rosuvastatin Calcium Value Chain Analysis
8.1.1 Rosuvastatin Calcium Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Rosuvastatin Calcium Production Mode & Process
8.2 Rosuvastatin Calcium Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Rosuvastatin Calcium Distributors
8.2.3 Rosuvastatin Calcium Customers
9 Global Rosuvastatin Calcium Analyzing Market Dynamics
9.1 Rosuvastatin Calcium Industry Trends
9.2 Rosuvastatin Calcium Industry Drivers
9.3 Rosuvastatin Calcium Industry Opportunities and Challenges
9.4 Rosuvastatin Calcium Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings